Scilex Holding (SCLX) Other Accumulated Expenses (2020 - 2026)

Scilex Holding (SCLX) recorded quarterly Other Accumulated Expenses of $255000.0 in Q1 2026, down 99.89% quarter-over-quarter from $231.8 million in Q4 2025, and down 99.85% on a YoY basis from $168.4 million in Q1 2025.

Scilex Holding (SCLX) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

Scilex Holding's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $255000.0 for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses fell 99.85% year-over-year to $255000.0; the TTM figure through Mar 2026 stood at $255000.0 (down 99.85% YoY), while the FY2025 annual figure was $231.8 million, changed N/A from the prior year.
  • Other Accumulated Expenses was $255000.0 for Q1 2026 at Scilex Holding, down from $231.8 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $231.8 million in Q4 2025 to a low of $255000.0 in Q1 2026.
  • Historically, Other Accumulated Expenses has averaged $93.4 million across 5 years, with a median of $89.7 million in 2023.
  • The sharpest annual moves came in 2024 and 2026: Other Accumulated Expenses soared 984.25% in 2024, then plunged 99.85% in 2026.
  • A 5-year view of Other Accumulated Expenses shows it stood at $30.9 million in 2022, then surged by 190.22% to $89.7 million in 2023, then jumped by 58.06% to $141.7 million in 2024, then jumped by 63.54% to $231.8 million in 2025, then tumbled by 99.89% to $255000.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $255000.0 (Q1 2026), $231.8 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 255,000.00
Dec 31, 2025 231.76 Mn
Sep 30, 2025 5.74 Mn
Jun 30, 2025 192.94 Mn
Mar 31, 2025 168.43 Mn
Sep 30, 2024 141.71 Mn
Jun 30, 2024 125.06 Mn
Mar 31, 2024 104.09 Mn
Dec 31, 2023 89.66 Mn
Sep 30, 2023 65.80 Mn
Jun 30, 2023 47.78 Mn
Mar 31, 2023 9.60 Mn
Dec 31, 2022 30.89 Mn
Dec 31, 2021 7.36 Mn
Dec 31, 2020 25,760.00